GLP-1 tapering and long-term weight management If youre taking a GLP-1 for type 2 diabetes, you will likely stay on your maintenance dose unless your doctor recommends otherwise
It remains unclear whether the imbalanced pharmacology or the longer half-life of tirzepatide contributes to its superior efficacy in glucose and weight reduction compared to the more balanced dual agonist, NNC0090-2746
Because peace of mind matters
Due to the fact that GLP-1 acting drugs such as dulaglutide, liraglutide, and semaglutide do not need dosage adjustments for patients with renal impairment, these medications are considered to be the most recommended choices for patients who have chronic kidney disease (Zheng et al
Azagury says, adding that more research is needed to confirm any link to mental health
Mitochondrial uncoupling proteins The mitochondrial uncoupling proteins (UCP-1, UCP-2 and UCP-3) have been suggested to be involved in the development of obesity by controlling the energy expenditure